Evidence of early onset of antidepressant effect in randomized controlled trials

Journal of Clinical Psychiatry

Volumn 62, Issue SUPPL. 4, 2001, Pages 17-23

  Stahl, S M ^a   Nierenberg, A A ^a   Gorman, J M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIDEPRESSANT AGENT; CITALOPRAM; FLUOXETINE; IMIPRAMINE; MIANSERIN; MIRTAZAPINE; PAROXETINE; PLACEBO; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG; VENLAFAXINE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; HEALTH CARE COST; HEALTH CARE QUALITY; HUMAN; LATENT PERIOD; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SUICIDE; TREATMENT OUTCOME;

ANTIDEPRESSIVE AGENTS; CITALOPRAM; CYCLOHEXANOLS; DEPRESSIVE DISORDER; DRUG ADMINISTRATION SCHEDULE; FLUOXETINE; HUMANS; MIANSERIN; PERSONALITY INVENTORY; PLACEBOS; RANDOMIZED CONTROLLED TRIALS; SEROTONIN UPTAKE INHIBITORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 0035119525     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Antagonism by antidepressants of neurotransmitter receptors of normal human brain in vitro
2. The pharmacology of citalopram
3. Validity, reliability and utility of the chronic mild stress model of depression: A 10-year review and evaluation
4. 2 ligand Lu 28-179 has an antidepressant-like profile in the rat chronic mild stress model of depression
5. 1A receptor ligands in a chronic mild stress model of depression
6. Identification of true drug response to antidepressants: Use of pattern analysis
7. Double-blind comparison of citalopram and placebo in depressed outpatients with melancholia
8. Comparison between zimeldine and amitriptyline of efficacy and adverse symptoms: A combined analysis of four British clinical trials in depression
9. Multicenter, placebo-controlled, fixed-dose study of citalopram in moderate to severe depression
10. Citalopram versus fluoxetine: A double-blind, controlled, multicentre, phase III trial in patients with unipolar major depression treated in general practice
11. Citalopram and fluoxetine in major depression: Comparison of two clinical trials in a psychiatrist setting and in general practice
12. Placebo-controlled comparison of the selective serotonin reuptake inhibitors citalopram and sertraline
13. Citalopram versus imipramine in the treatment of inpatient depression: Results from a double-blind, placebo-controlled trial
14. Citalopram versus mianserin: A controlled, double-blind trial in depressed patients
15. Antidepressant biochemical profile of the novel bicyclic compound Wy-45,030, an ethyl cyclohexanol derivative
16. Evidence of the dual mechanisms of action of venlafaxine
17. A double-blind comparison of venlafaxine and fluoxetine in patients hospitalized for major depression and melancholia
18. Venlafaxine and paroxetine in treatment-resistant depression: Double-blind, randomised comparison
19. A double-blind, randomized, placebo-controlled trial of once-daily venlafaxine extended release (XR) and fluoxetine for the treatment of depression
20. Comparison of remission rates during drug treatment with venlafaxine or serotonin selective reuptake inhibitors: A pooled analysis of original data from 2045 depressed patients
21. Venlafaxine: Measuring the onset of antidepressant action
22. Placebo-controlled trial of venlafaxine for the treatment of major depression
23. A dose-response study of venlafaxine
24. Effectiveness of venlafaxine in patients hospitalized for major depression and melancholia
25. Early onset of antidepressant activity of venlafaxine compared with placebo and fluoxetine in outpatients in a double-blind study
26. 1A receptors
27. Differences in modulation of noradrenergic and serotonergic transmission by the alpha-2 adrenoceptor antagonists, mirtazapine, mianserin and idazoxan
28. A double-blind placebo-controlled study of Org 3770 in depressed outpatients
29. Efficacy and tolerability of mirtazapine versus citalopram: A double-blind, randomized study in patients with major depressive disorder
30. Mirtazapine and the onset of antidepressant action: Survival function analysis-response
31. Use of pattern analysis to identify true drug response: A replication
32. Time course of improvement under antidepressant treatment: A survival-analytical approach
33. The definition and operational criteria for treatment outcome of major depressive disorder: A review of the current research literature
34. Cardiovascular safety in depressed patients: Focus on venlafaxine
35. Effects of venlafaxine on blood pressure: A meta-analysis of original data from 3744 depressed patients